Notalgia Paresthetica Dermatologist Report of Symptom Burden and Treatment: Results from a Physician Survey
DOI:
https://doi.org/10.2340/actadv.v104.39941Keywords:
Notalgia paresthetica, pruritus, neuropathic itch, sensory neuropathy, dermatologist, physician surveyAbstract
Notalgia paresthetica (NP) is a sensory neuropathy characterized by chronic pruritus, skin pain, and other pathologic sensations affecting the mid-to-upper back. NP may be under-recognized and under-diagnosed, with limited data available on its symptom presentation and treatment patterns. NP-DERM was an internet-based survey of dermatologists (n = 650) from 8 different countries on their perspectives on NP symptoms and current treatment practices. Dermatologists typically treated a median of 12 patients with NP per month. Dermatologists reported that itch (pruritus) was the most common symptom for their patients with NP, followed by hyperpigmentation and sensitive skin. The most burdensome NP symptom was pruritus, followed by burning or hot sensation, and painful or raw skin. The most prescribed treatments included non-medicated skin care, topical corticosteroids, oral antihistamines, medicated topicals, and gabapentin or pregabalin. Physicians reported low satisfaction with available treatments. The most common reason for physicians to discontinue patients’ therapy was lack of response.
Downloads
References
Bacci ED, Currie BM, Wilson R, Qian J, Munera C, Nograles K. Understanding the patient experience of living with notalgia paresthetica: a qualitative interview study. JAAD Int 2022; 8: 94-101.
https://doi.org/10.1016/j.jdin.2022.04.003 DOI: https://doi.org/10.1016/j.jdin.2022.04.003
Auyeung KL, Kim BS. Emerging concepts in neuropathic and neurogenic itch. Ann Allergy Asthma Immunol 2023; 131: 561-566.
https://doi.org/10.1016/j.anai.2023.08.008 DOI: https://doi.org/10.1016/j.anai.2023.08.008
Robinson C, Downs E, De la Caridad Gomez Y, Nduaguba C, Woolley P, Varrassi G, et al. Notalgia paresthetica review: update on presentation, pathophysiology, and treatment. Clin Pract 2023; 13: 315-325.
https://doi.org/10.3390/clinpract13010029 DOI: https://doi.org/10.3390/clinpract13010029
Šitum M, Kolić M, Franceschi N, Pećina M. Notalgia paresthetica. Acta Clin Croat 2018; 57: 721-725.
https://doi.org/10.20471/acc.2018.57.04.14 DOI: https://doi.org/10.20471/acc.2018.57.04.14
Howard M, Sahhar L, Andrews F, Bergman R, Gin D. Notalgia paresthetica: a review for dermatologists. Int J Dermatol 2018; 57: 388-392.
https://doi.org/10.1111/ijd.13853 DOI: https://doi.org/10.1111/ijd.13853
Pereira MP, Lüling H, Dieckhöfer A, Steinke S, Zeidler C, Ständer S. Brachioradial pruritus and notalgia paraesthetica: a comparative observational study of clinical presentation and morphological pathologies. Acta Derm Venereol 2018; 98: 82-88.
https://doi.org/10.2340/00015555-2789 DOI: https://doi.org/10.2340/00015555-2789
Huesmann T, Cunha PR, Osada N, Huesmann M, Zanelato TP, Phan NQ, et al. Notalgia paraesthetica: a descriptive two-cohort study of 65 patients from Brazil and Germany. Acta Derm Venereol 2012; 92: 535-540.
https://doi.org/10.2340/00015555-1344 DOI: https://doi.org/10.2340/00015555-1344
Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999; 135: 1522-1525.
https://doi.org/10.1001/archderm.135.12.1522 DOI: https://doi.org/10.1001/archderm.135.12.1522
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Brian S. Kim, Sonja Ständer, Kenji Kabashima, Jennifer A. Mohawk, Sherri So, Joana Goncalves, Nilam Shah, Catherine Munera, Joseph C. Punzalan, Romelia Argudo, Mark Lebwohl
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
